What is The Billion Dollar Blindspot?
The Billion Dollar Blindspot is a weekly newsletter that decodes how capital, innovation, and incentives shape women’s health.
We explore why women’s bodies are so often misunderstood, under-researched, and dismissed and what happens when medicine, data, and capital fail to account for half the population.
Through sharp analysis, lived experience, and investigative storytelling, we help readers understand what’s really happening in women’s health and why it’s happening at all.
Rather than focusing on individual companies or headlines alone, we connect clinical realities, innovation pipelines, and capital flows to explain how decisions actually get made, what gets funded, and why certain categories remain misunderstood for far longer than fundamentals would suggest.
What You’ll Find Here
Weekly capital briefings that follow the money:
Analysis of women’s health innovation and investment dynamics
Narrative essays that reveal structural patterns in medicine and markets
Insight into how capital allocation actually works and how systems get built (or don’t)
Monthly deep-dives on the deals, developments, and decisions that matter explained through a capital lens.
Founder stories that show the real journey of building in women’s health, from first check to exit (or everything in between).
Women’s health serves as the lens, because it is one of the clearest places to observe how assumptions, data gaps, and incentives quietly shape outcomes.
Who This Is For
This space is for people who are curious about how capital shapes the world. Many of our readers are professionals who care deeply about impact, outcomes, and long-term value, but have not had a front row seat to observe how capital decisions are made or how participation begins.
You may be:
Navigating your own health journey and wanting to understand the system, not just survive it
A professional (in finance, consulting, health, or tech) seeking ecosystem intelligence
A content creator, writer, or advocate amplifying women’s health
A healthcare operator (founder, clinician, researcher) wanting capital landscape clarity
An emerging angel investor exploring private markets in women’s health
A foundation director, family office member, or wealth inheritor seeking mission-aligned opportunities
You do not need to be an investor to be here. You only need curiosity about how money, systems, and incentives influence which innovations reach the world and which never do.
Here’s what readers had to say
About Me
I’m Maryann Selfe, an investment strategist with more than twenty years of experience advising private clients, ultra-high-net-worth families, and institutions across market cycles.
Before focusing on women’s health, I spent two decades inside the financial system working closely with private and institutional investors on portfolio construction, risk management, liquidity events, and long-term wealth planning. That work offered sustained exposure to how capital behaves, how decisions compound over time, and how access (or the lack of it) shapes opportunity.
My writing today sits at the intersection of healthcare innovation and capital markets.
Women’s health is a category where structural assumptions, data availability, and funding dynamics can be observed with unusual clarity making it an ideal lens for understanding how markets truly function.
Capital is the through-line: how it moves, where it hesitates, and how long-term value is ultimately created.
Going Deeper
Paid subscribers get access to deep analysis, paywalled frameworks, monthly deep-dives, founder interviews, live office hours, and a community of people who want to understand the system.
⚖️ Disclaimer
All content shared by The Billion Dollar Blindspot is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. We do not act as a broker-dealer, registered investment advisor, or placement agent in this context. Always consult with a licensed financial or legal advisor before making investment decisions.
